Sophie-Charlotte Hofferberth, MD

Co-Founder, President, Chief Medical Officer

Dr Sophie-Charlotte Hofferberth is Co-founder, President and Chief Medical Officer of Autus Valve Technologies, Inc. As a post-doctoral research fellow in the Department of Cardiac Surgery at Boston Children’s Hospital, Dr Hofferberth led the conception, design and development of the novel Autus Size-Adjustable Valve technology. Dr Hofferberth designed and led the pre-clinical bench and animal studies that culminated in FDA approval for a U.S Early Feasibility Study and the first-in-human Autus Valve implant. Under Dr Hofferberth's leadership, the Company successfully completed the U.S Early Feasibility Study, obtained FDA Breakthrough Device Designation and received unconditional FDA approval to conduct the U.S Pivotal Study.

Dr Hofferberth received her medical degree from the University of Melbourne Medical School and she is a cardiothoracic surgery resident at Brigham and Women’s Hospital, Harvard Medical School. Dr Hofferberth has taken a leave of absence from her surgical training to lead the development of the Autus Valve.